We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
16.9
quarters
Top 10 Avg Time Held Equity + Options
5.9
quarters
Top 20 Avg Time Held Equity + Options
16.1
quarters
Avg Time Held Equity only
16.9
quarters
Top 10 Avg Time Held Equity only
5.9
quarters
Top 20 Avg Time Held Equity only
16.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4051
Standard BioTools
LAB
$271M
| $17K | ﹤0.01% |
18,468
-27,567
| -60% | -$33.4K |
2024 Q3
6 quarters
|
|
4052
Lucid Diagnostics
LUCD
$122M
| $16.6K | ﹤0.01% |
14,420
+2,553
| +22% | +$3.25K |
2024 Q4
5 quarters
|
|
|
CIF
4053
DELISTED
MFS Intermediate High Income Fund
CIF
| $16.2K | ﹤0.01% |
+10,011
| New | +$16.9K |
2026 Q1
0 quarters
|
|
4054
Milestone Pharmaceuticals
MIST
$95.2M
| $16K | ﹤0.01% |
13,410
-10,000
| -43% | -$17.5K |
2022 Q4
13 quarters
|
|
4055
CALL
POET Technologies
POET
$1.21B
| $15.9K | ﹤0.01% |
10,000
| – | – |
2025 Q1
4 quarters
|
|
4056
JELD-WEN Holding
JELD
$134M
| $14.6K | ﹤0.01% |
+11,811
| New | +$25.8K |
2026 Q1
0 quarters
|
|
4057
Xerox
XRX
$361M
| $13.6K | ﹤0.01% |
10,530
-55,766
| -84% | -$110K |
2024 Q3
6 quarters
|
|
4058
SkinHealth Systems
SKIN
$71.6M
| $13.2K | ﹤0.01% |
14,885
-939
| -6% | -$1.15K |
2025 Q4
1 quarter
|
|
4059
DELISTED
WM TECHNOLOGY INC A
MAPS
| $13.2K | ﹤0.01% |
+20,085
| New | +$14.7K |
2026 Q1
0 quarters
|
|
4060
Zevia
ZVIA
$87.3M
| $12.6K | ﹤0.01% |
+10,763
| New | +$17.1K |
2026 Q1
0 quarters
|
|
|
FFAI
4061
Faraday Future Intelligent Electric
FFAI
$6.74M
| $12.5K | ﹤0.01% |
+302
| New | +$31.2K |
2026 Q1
0 quarters
|
|
4062
Wheels Up
UP
$138M
| $12.4K | ﹤0.01% |
+1,198
| New | +$15.6K |
2026 Q1
0 quarters
|
|
4063
Oncolytics Biotech
ONCY
$73M
| $12.3K | ﹤0.01% |
14,545
+1,215
| +9% | +$1.21K |
2024 Q3
6 quarters
|
|
4064
Diginex Ltd
DGNX
$37M
| $12.3K | ﹤0.01% |
+3,200
| New | +$31.1K |
2026 Q1
0 quarters
|
|
4065
Cytosorbents Corp
CTSO
$11.9M
| $12.1K | ﹤0.01% |
1,065
| – | – |
2018 Q2
31 quarters
|
|
4066
Castellum
CTM
$59M
| $12K | ﹤0.01% |
20,320
+320
| +2% | +$286 |
2025 Q1
4 quarters
|
|
4067
Westwater Resources
WWR
$58.5M
| $11.4K | ﹤0.01% |
17,415
| – | – |
2023 Q4
9 quarters
|
|
4068
Airship AI Holdings Warrants
AISPW
$19M
| $10.6K | ﹤0.01% |
15,000
| – | – |
2025 Q1
4 quarters
|
|
4069
CALL
Archer Aviation
ACHR
$3.82B
| $10.4K | ﹤0.01% |
10,000
| – | – |
2025 Q2
3 quarters
|
|
4070
Zeo Energy
ZEO
$12.3M
| $9.92K | ﹤0.01% |
17,278
| – | – |
2025 Q3
2 quarters
|
|
4071
SCYNEXIS
SCYX
$40.6M
| $9.78K | ﹤0.01% |
1,334
-245
| -16% | -$1.51K |
2025 Q3
2 quarters
|
|
4072
Teads Holding Co
TEAD
$53.3M
| $9.76K | ﹤0.01% |
+14,825
| New | +$10.5K |
2026 Q1
0 quarters
|
|
4073
Defi Technologies
DEFT
$181M
| $9.69K | ﹤0.01% |
17,534
-5
| -0% | -$4 |
2025 Q4
1 quarter
|
|
4074
Banzai International
PARA
$2.98M
| $9.64K | ﹤0.01% |
+507
| New | +$12.2K |
2026 Q1
0 quarters
|
|
4075
NeuroSense Therapeutics
NRSN
$6.94M
| $8.99K | ﹤0.01% |
596
| – | – |
2025 Q4
1 quarter
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.